89 related articles for article (PubMed ID: 4151761)
1. Tissue accumulation of metabolites during chronic administration of piperazine-substituted phenothiazine drugs.
Breyer U; Gaertner HJ
Adv Biochem Psychopharmacol; 1974; 9(0):167-73. PubMed ID: 4151761
[No Abstract] [Full Text] [Related]
2. Metabolism of trifluoperazine, fluphenazine, prochlorperazine and perphenazine in rats: in vitro and urinary metabolites.
Gaertner HJ; Breyer U; Liomin G
Biochem Pharmacol; 1974 Jan; 23(2):303-11. PubMed ID: 4813347
[No Abstract] [Full Text] [Related]
3. Tissue metabolites of trifluorperazine, fluphenazine, prochlorperazine, and perphenazine. Kinetics in chronic treatment.
Gaertner HJ; Liomin G; Villumsen D; Bertele R; Breyer U
Drug Metab Dispos; 1975; 3(6):437-44. PubMed ID: 1218
[TBL] [Abstract][Full Text] [Related]
4. Formation of identical metabolites from piperazine- and dimethylamino-substituted phenothiazine drugs in man, rat and dog.
Breyer U; Gaertner HJ; Prox A
Biochem Pharmacol; 1974 Jan; 23(2):313-22. PubMed ID: 4813348
[No Abstract] [Full Text] [Related]
5. Tissue metabolites of trifluoperazine, fluphenazine, prochlorperazine, and perphenazine in the rat: indentification and synthesis.
Breyer U; Prox A; Bertele R; Gaertner HJ
J Pharm Sci; 1974 Dec; 63(12):1842-8. PubMed ID: 4449013
[No Abstract] [Full Text] [Related]
6. Chronic administration of chlorcyclizine and meclizine to rats: accumulation of a metabolite formed by piperazine ring cleavage.
Gaertner HJ; Breyer U; Liomin G
J Pharmacol Exp Ther; 1973 May; 185(2):195-201. PubMed ID: 4145042
[No Abstract] [Full Text] [Related]
7. In vivo piperazine ring degradation in neuroleptic and antihistaminic drugs.
Gaertner HJ; Breyer U
Arzneimittelforschung; 1972 Jun; 22(6):1084-5. PubMed ID: 4403218
[No Abstract] [Full Text] [Related]
8. The rat brain as a "deep compartment" in the kinetics of a common metabolite of prochlorperazine and perphenazine.
Jahns I; Breyer U
Drug Metab Dispos; 1976; 4(6):522-9. PubMed ID: 11973
[TBL] [Abstract][Full Text] [Related]
9. The binding of phenothiazines to oxyhemoglobin A and S.
Wind M; Berliner A; Stella AS; Guttman C
Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):759-66. PubMed ID: 4144819
[No Abstract] [Full Text] [Related]
10. Microsomal mixed-function amine oxidase. Oxidation products of piperazine-substituted phenothiazine drugs.
Sofer SS; Ziegler DM
Drug Metab Dispos; 1978; 6(3):232-9. PubMed ID: 26542
[TBL] [Abstract][Full Text] [Related]
11. The use of combined gas chromatography-mass spectrometry techniques for the identification of hydroxylated and dihydroxylated metabolites of phenothiazine drugs.
Craig JC; Garland WA; Gruenke LD; Kray LR; Walker KA
Adv Biochem Psychopharmacol; 1974; 9(0):405-11. PubMed ID: 4151766
[No Abstract] [Full Text] [Related]
12. Detection of some psychotherapeutic drugs and their metabolites in urine.
Garriott JC; Stolman A
Clin Toxicol; 1971 Jun; 4(2):225-43. PubMed ID: 5097493
[No Abstract] [Full Text] [Related]
13. Metabolism and disposition of trifluoperazine in the rat. I. A thin-layer chromatographic method for the measurement of trifluoperazine and its metabolites in rat tissues.
Breyer U; Schmalzing G
Drug Metab Dispos; 1977; 5(2):97-103. PubMed ID: 15817
[TBL] [Abstract][Full Text] [Related]
14. Studies on an unusual N-dealkylation reaction. I. In vivo and in vitro N-dealkylation of N-t-butylnorchlorcyclizine to norchlorcyclizine by the rat.
Kamm JJ; Szuna A; Kuntzman R
J Pharmacol Exp Ther; 1972 Sep; 182(3):507-14. PubMed ID: 4403434
[No Abstract] [Full Text] [Related]
15. [Study of phenothiazine binding to membranes by the fluorescent probe method].
Deev AI; Iarova EA; Dobretsov GE
Farmakol Toksikol; 1977; 40(3):351-5. PubMed ID: 20327
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the structure of liposomal membrane surface layer on the binding of phenothiazines].
Iarova EA; Deev AI; Kovaleva NS; Ivkov NN
Farmakol Toksikol; 1978; 41(1):8-12. PubMed ID: 23960
[TBL] [Abstract][Full Text] [Related]
17. [Longitudinal studies on the metabolite pattern of perazine and related phenothiazines in human and animal].
Breyer U
Arzneimittelforschung; 1974 Jul; 24(7):989-90. PubMed ID: 4152695
[No Abstract] [Full Text] [Related]
18. Two types of metabolically produced trifluoperazine N-oxides.
Spirtes MA
Adv Biochem Psychopharmacol; 1974; 9(0):399-404. PubMed ID: 4836216
[No Abstract] [Full Text] [Related]
19. Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects.
Snyder SH; Greenberg D; Yamumura HI
J Psychiatr Res; 1974; 11():91-5. PubMed ID: 4156796
[No Abstract] [Full Text] [Related]
20. In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review.
Otręba M; Kośmider L
J Appl Toxicol; 2021 Jan; 41(1):82-94. PubMed ID: 32852120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
